Content area
Full Text
Oncogene (2003) 22, 42214234
& 2003 Nature Publishing Group All rights reserved 0950-9232/03 $25.00www.nature.com/oncFeedback inhibition by RALT controls signal output by the ErbB networkSergio Anastasi1,6, Loredana Fiorentino1,6,7, Monia Fiorini1, Rocco Fraioli1, Gianluca Sala1,
L Castellani2,3, Stefano Alema4, Maurizio Alimandi5 and Oreste Segatton,11Regina Elena Cancer Institute, Via Delle Messi dOro, 156, Rome 00158, Italy; 2University of Cassino, Cassino, Italy; 3INFM Sez.
B, University of Rome Tor Vergata, Rome, Italy;4Istituto di Biologia Cellulare, CNR Monterotondo 00016, Italy; 5Department ofExperimental Medicine, University of Rome La Sapienza, Viale Regina Elena 324, Rome 00161, ItalyThe ErbB-2 interacting protein receptor-associated late
transducer (RALT) was previously identied as a feedback inhibitor of ErbB-2 mitogenic signals. We now
report that RALT binds to ligand-activated epidermal
growth factor receptor (EGFR), ErbB-4 and ErbB-
2.ErbB-3 dimers. When ectopically expressed in 32D
cells reconstituted with the above ErbB receptor tyrosine
kinases (RTKs) RALT behaved as a pan-ErbB inhibitor.
Importantly, when tested in either cell proliferation assays
or biochemical experiments measuring activation of ERK
and AKT, RALT affected the signalling activity of
distinct ErbB dimers with different relative potencies.
RALT DEBR, a mutant unable to bind to ErbB RTKs, did
not inhibit ErbB-dependent activation of ERK and AKT,
consistent with RALT exerting its suppressive activity
towards these pathways at a receptor-proximal level.
Remarkably, RALT DEBR retained the ability to
suppress largely the proliferative activity of ErbB-
2.ErbB-3 dimers over a wide range of ligand concentrations, indicating that RALT can intercept ErbB-2.ErbB-3
mitogenic signals also at a receptor-distal level. A
suppressive function of RALT DEBR towards the
mitogenic activity of EGFR and ErbB-4 was detected at
low levels of receptor occupancy, but was completely
overcome by saturating concentrations of ligand. We
propose that quantitative and qualitative aspects of RALT
signalling concur in dening identity, strength and
duration of signals generated by the ErbB network.
Oncogene (2003) 22, 42214234. doi:10.1038/sj.onc.1206516Keywords: ErbB; feedback inhibition; Mig-6; negative
signaling; RALTIntroductionThe family of ErbB receptor tyrosine kinases (RTKs)
consists of four members: ErbB-1 (also referred to as
epidermal growth factor receptor, EGFR) through
ErbB-4. In the human genome, a dozen 10 genes encode
ErbB ligands possessing distinct receptor specicity.
Regardless of the latter, all ErbB ligands trigger cognate
receptors via a common mechanism entailing the
assembly of homo- and heterodimeric receptor combinations (reviewed...